Summary
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
According to APO Research, The global Respiratory Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Respiratory Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Respiratory Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Respiratory Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Respiratory Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Respiratory Drug include GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, Novartis, Teva, Chiesi and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Respiratory Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Respiratory Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Respiratory Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Respiratory Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Respiratory Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Respiratory Drug sales, projected growth trends, production technology, application and end-user industry.
Respiratory Drug segment by Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
Respiratory Drug segment by Type
Inhalable & Nasal Spray
Oral
Others
Respiratory Drug segment by Application
Hospital
Drugs Store
Respiratory Drug segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Respiratory Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Respiratory Drug Market by Type
1.2.1 Global Respiratory Drug Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Respiratory Drug Market by Application
1.3.1 Global Respiratory Drug Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Respiratory Drug Market Dynamics
2.1 Respiratory Drug Industry Trends
2.2 Respiratory Drug Industry Drivers
2.3 Respiratory Drug Industry Opportunities and Challenges
2.4 Respiratory Drug Industry Restraints
3 Global Market Growth Prospects
3.1 Global Respiratory Drug Revenue Estimates and Forecasts (2019-2030)
3.2 Global Respiratory Drug Revenue by Region
3.2.1 Global Respiratory Drug Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Respiratory Drug Revenue by Region (2019-2024)
3.2.3 Global Respiratory Drug Revenue by Region (2025-2030)
3.2.4 Global Respiratory Drug Revenue Market Share by Region (2019-2030)
3.3 Global Respiratory Drug Sales Estimates and Forecasts 2019-2030
3.4 Global Respiratory Drug Sales by Region
3.4.1 Global Respiratory Drug Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Respiratory Drug Sales by Region (2019-2024)
3.4.3 Global Respiratory Drug Sales by Region (2025-2030)
3.4.4 Global Respiratory Drug Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Respiratory Drug Revenue by Manufacturers
4.1.1 Global Respiratory Drug Revenue by Manufacturers (2019-2024)
4.1.2 Global Respiratory Drug Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Respiratory Drug Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Respiratory Drug Sales by Manufacturers
4.2.1 Global Respiratory Drug Sales by Manufacturers (2019-2024)
4.2.2 Global Respiratory Drug Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Respiratory Drug Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Respiratory Drug Sales Price by Manufacturers (2019-2024)
4.4 Global Respiratory Drug Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Respiratory Drug Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Respiratory Drug Manufacturers, Product Type & Application
4.7 Global Respiratory Drug Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Respiratory Drug Market CR5 and HHI
4.8.2 2023 Respiratory Drug Tier 1, Tier 2, and Tier 3
5 Respiratory Drug Market by Type
5.1 Global Respiratory Drug Revenue by Type
5.1.1 Global Respiratory Drug Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Respiratory Drug Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Respiratory Drug Revenue Market Share by Type (2019-2030)
5.2 Global Respiratory Drug Sales by Type
5.2.1 Global Respiratory Drug Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Respiratory Drug Sales by Type (2019-2030) & (M Units)
5.2.3 Global Respiratory Drug Sales Market Share by Type (2019-2030)
5.3 Global Respiratory Drug Price by Type
6 Respiratory Drug Market by Application
6.1 Global Respiratory Drug Revenue by Application
6.1.1 Global Respiratory Drug Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Respiratory Drug Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Respiratory Drug Revenue Market Share by Application (2019-2030)
6.2 Global Respiratory Drug Sales by Application
6.2.1 Global Respiratory Drug Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Respiratory Drug Sales by Application (2019-2030) & (M Units)
6.2.3 Global Respiratory Drug Sales Market Share by Application (2019-2030)
6.3 Global Respiratory Drug Price by Application
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Respiratory Drug Product Portfolio
7.1.5 GSK Recent Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Comapny Information
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 AstraZeneca Respiratory Drug Product Portfolio
7.2.5 AstraZeneca Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Comapny Information
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio
7.3.5 Boehringer Ingelheim Recent Developments
7.4 Vertex
7.4.1 Vertex Comapny Information
7.4.2 Vertex Business Overview
7.4.3 Vertex Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Vertex Respiratory Drug Product Portfolio
7.4.5 Vertex Recent Developments
7.5 Roche
7.5.1 Roche Comapny Information
7.5.2 Roche Business Overview
7.5.3 Roche Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Roche Respiratory Drug Product Portfolio
7.5.5 Roche Recent Developments
7.6 Novartis
7.6.1 Novartis Comapny Information
7.6.2 Novartis Business Overview
7.6.3 Novartis Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Novartis Respiratory Drug Product Portfolio
7.6.5 Novartis Recent Developments
7.7 Teva
7.7.1 Teva Comapny Information
7.7.2 Teva Business Overview
7.7.3 Teva Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Teva Respiratory Drug Product Portfolio
7.7.5 Teva Recent Developments
7.8 Chiesi
7.8.1 Chiesi Comapny Information
7.8.2 Chiesi Business Overview
7.8.3 Chiesi Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Chiesi Respiratory Drug Product Portfolio
7.8.5 Chiesi Recent Developments
7.9 Mylan
7.9.1 Mylan Comapny Information
7.9.2 Mylan Business Overview
7.9.3 Mylan Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Mylan Respiratory Drug Product Portfolio
7.9.5 Mylan Recent Developments
7.10 Sumitomo Dainippon
7.10.1 Sumitomo Dainippon Comapny Information
7.10.2 Sumitomo Dainippon Business Overview
7.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio
7.10.5 Sumitomo Dainippon Recent Developments
7.11 Merck
7.11.1 Merck Comapny Information
7.11.2 Merck Business Overview
7.11.3 Merck Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Merck Respiratory Drug Product Portfolio
7.11.5 Merck Recent Developments
7.12 Beximco
7.12.1 Beximco Comapny Information
7.12.2 Beximco Business Overview
7.12.3 Beximco Respiratory Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Beximco Respiratory Drug Product Portfolio
7.12.5 Beximco Recent Developments
8 North America
8.1 North America Respiratory Drug Market Size by Type
8.1.1 North America Respiratory Drug Revenue by Type (2019-2030)
8.1.2 North America Respiratory Drug Sales by Type (2019-2030)
8.1.3 North America Respiratory Drug Price by Type (2019-2030)
8.2 North America Respiratory Drug Market Size by Application
8.2.1 North America Respiratory Drug Revenue by Application (2019-2030)
8.2.2 North America Respiratory Drug Sales by Application (2019-2030)
8.2.3 North America Respiratory Drug Price by Application (2019-2030)
8.3 North America Respiratory Drug Market Size by Country
8.3.1 North America Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Respiratory Drug Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Respiratory Drug Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Respiratory Drug Market Size by Type
9.1.1 Europe Respiratory Drug Revenue by Type (2019-2030)
9.1.2 Europe Respiratory Drug Sales by Type (2019-2030)
9.1.3 Europe Respiratory Drug Price by Type (2019-2030)
9.2 Europe Respiratory Drug Market Size by Application
9.2.1 Europe Respiratory Drug Revenue by Application (2019-2030)
9.2.2 Europe Respiratory Drug Sales by Application (2019-2030)
9.2.3 Europe Respiratory Drug Price by Application (2019-2030)
9.3 Europe Respiratory Drug Market Size by Country
9.3.1 Europe Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Respiratory Drug Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Respiratory Drug Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Respiratory Drug Market Size by Type
10.1.1 China Respiratory Drug Revenue by Type (2019-2030)
10.1.2 China Respiratory Drug Sales by Type (2019-2030)
10.1.3 China Respiratory Drug Price by Type (2019-2030)
10.2 China Respiratory Drug Market Size by Application
10.2.1 China Respiratory Drug Revenue by Application (2019-2030)
10.2.2 China Respiratory Drug Sales by Application (2019-2030)
10.2.3 China Respiratory Drug Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Respiratory Drug Market Size by Type
11.1.1 Asia Respiratory Drug Revenue by Type (2019-2030)
11.1.2 Asia Respiratory Drug Sales by Type (2019-2030)
11.1.3 Asia Respiratory Drug Price by Type (2019-2030)
11.2 Asia Respiratory Drug Market Size by Application
11.2.1 Asia Respiratory Drug Revenue by Application (2019-2030)
11.2.2 Asia Respiratory Drug Sales by Application (2019-2030)
11.2.3 Asia Respiratory Drug Price by Application (2019-2030)
11.3 Asia Respiratory Drug Market Size by Country
11.3.1 Asia Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Respiratory Drug Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Respiratory Drug Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Respiratory Drug Market Size by Type
12.1.1 MEALA Respiratory Drug Revenue by Type (2019-2030)
12.1.2 MEALA Respiratory Drug Sales by Type (2019-2030)
12.1.3 MEALA Respiratory Drug Price by Type (2019-2030)
12.2 MEALA Respiratory Drug Market Size by Application
12.2.1 MEALA Respiratory Drug Revenue by Application (2019-2030)
12.2.2 MEALA Respiratory Drug Sales by Application (2019-2030)
12.2.3 MEALA Respiratory Drug Price by Application (2019-2030)
12.3 MEALA Respiratory Drug Market Size by Country
12.3.1 MEALA Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Respiratory Drug Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Respiratory Drug Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Respiratory Drug Value Chain Analysis
13.1.1 Respiratory Drug Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Respiratory Drug Production Mode & Process
13.2 Respiratory Drug Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Respiratory Drug Distributors
13.2.3 Respiratory Drug Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Respiratory Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Inhalable & Nasal Spray Major Manufacturers
Table 3. Oral Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Respiratory Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Hospital Major Manufacturers
Table 7. Drugs Store Major Manufacturers
Table 8. Respiratory Drug Industry Trends
Table 9. Respiratory Drug Industry Drivers
Table 10. Respiratory Drug Industry Opportunities and Challenges
Table 11. Respiratory Drug Industry Restraints
Table 12. Global Respiratory Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Respiratory Drug Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Respiratory Drug Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Respiratory Drug Revenue Market Share by Region (2019-2024)
Table 16. Global Respiratory Drug Revenue Market Share by Region (2025-2030)
Table 17. Global Respiratory Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
Table 18. Global Respiratory Drug Sales by Region (2019-2024) & (M Units)
Table 19. Global Respiratory Drug Sales by Region (2025-2030) & (M Units)
Table 20. Global Respiratory Drug Sales Market Share by Region (2019-2024)
Table 21. Global Respiratory Drug Sales Market Share by Region (2025-2030)
Table 22. Global Respiratory Drug Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Respiratory Drug Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Respiratory Drug Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Respiratory Drug Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Respiratory Drug Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 27. Global Respiratory Drug Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Respiratory Drug Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Respiratory Drug Manufacturers, Product Type & Application
Table 30. Global Respiratory Drug Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Respiratory Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Respiratory Drug Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Respiratory Drug Revenue Market Share by Type (2019-2024)
Table 37. Global Respiratory Drug Revenue Market Share by Type (2025-2030)
Table 38. Global Respiratory Drug Sales by Type 2019 VS 2023 VS 2030 (M Units)
Table 39. Global Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 40. Global Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 41. Global Respiratory Drug Sales Market Share by Type (2019-2024)
Table 42. Global Respiratory Drug Sales Market Share by Type (2025-2030)
Table 43. Global Respiratory Drug Price by Type (2019-2024) & (US$/Unit)
Table 44. Global Respiratory Drug Price by Type (2025-2030) & (US$/Unit)
Table 45. Global Respiratory Drug Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Respiratory Drug Revenue Market Share by Application (2019-2024)
Table 49. Global Respiratory Drug Revenue Market Share by Application (2025-2030)
Table 50. Global Respiratory Drug Sales by Application 2019 VS 2023 VS 2030 (M Units)
Table 51. Global Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 52. Global Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 53. Global Respiratory Drug Sales Market Share by Application (2019-2024)
Table 54. Global Respiratory Drug Sales Market Share by Application (2025-2030)
Table 55. Global Respiratory Drug Price by Application (2019-2024) & (US$/Unit)
Table 56. Global Respiratory Drug Price by Application (2025-2030) & (US$/Unit)
Table 57. GSK Company Information
Table 58. GSK Business Overview
Table 59. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. GSK Respiratory Drug Product Portfolio
Table 61. GSK Recent Development
Table 62. AstraZeneca Company Information
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. AstraZeneca Respiratory Drug Product Portfolio
Table 66. AstraZeneca Recent Development
Table 67. Boehringer Ingelheim Company Information
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Boehringer Ingelheim Respiratory Drug Product Portfolio
Table 71. Boehringer Ingelheim Recent Development
Table 72. Vertex Company Information
Table 73. Vertex Business Overview
Table 74. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Vertex Respiratory Drug Product Portfolio
Table 76. Vertex Recent Development
Table 77. Roche Company Information
Table 78. Roche Business Overview
Table 79. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Roche Respiratory Drug Product Portfolio
Table 81. Roche Recent Development
Table 82. Novartis Company Information
Table 83. Novartis Business Overview
Table 84. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Novartis Respiratory Drug Product Portfolio
Table 86. Novartis Recent Development
Table 87. Teva Company Information
Table 88. Teva Business Overview
Table 89. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Teva Respiratory Drug Product Portfolio
Table 91. Teva Recent Development
Table 92. Chiesi Company Information
Table 93. Chiesi Business Overview
Table 94. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Chiesi Respiratory Drug Product Portfolio
Table 96. Chiesi Recent Development
Table 97. Mylan Company Information
Table 98. Mylan Business Overview
Table 99. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Mylan Respiratory Drug Product Portfolio
Table 101. Mylan Recent Development
Table 102. Sumitomo Dainippon Company Information
Table 103. Sumitomo Dainippon Business Overview
Table 104. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Sumitomo Dainippon Respiratory Drug Product Portfolio
Table 106. Sumitomo Dainippon Recent Development
Table 107. Merck Company Information
Table 108. Merck Business Overview
Table 109. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Merck Respiratory Drug Product Portfolio
Table 111. Merck Recent Development
Table 112. Beximco Company Information
Table 113. Beximco Business Overview
Table 114. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Beximco Respiratory Drug Product Portfolio
Table 116. Beximco Recent Development
Table 117. North America Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 118. North America Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 119. North America Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 120. North America Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 121. North America Respiratory Drug Sales Price by Type (2019-2024) & (US$/Unit)
Table 122. North America Respiratory Drug Sales Price by Type (2025-2030) & (US$/Unit)
Table 123. North America Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 124. North America Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 125. North America Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 126. North America Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 127. North America Respiratory Drug Sales Price by Application (2019-2024) & (US$/Unit)
Table 128. North America Respiratory Drug Sales Price by Application (2025-2030) & (US$/Unit)
Table 129. North America Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 130. North America Respiratory Drug Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 131. North America Respiratory Drug Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 132. North America Respiratory Drug Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 133. North America Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 134. North America Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 135. North America Respiratory Drug Sales Price by Country (2019-2024) & (US$/Unit)
Table 136. North America Respiratory Drug Sales Price by Country (2025-2030) & (US$/Unit)
Table 137. US Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 138. Canada Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 139. Europe Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 140. Europe Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 141. Europe Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 142. Europe Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 143. Europe Respiratory Drug Sales Price by Type (2019-2024) & (US$/Unit)
Table 144. Europe Respiratory Drug Sales Price by Type (2025-2030) & (US$/Unit)
Table 145. Europe Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 146. Europe Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 147. Europe Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 148. Europe Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 149. Europe Respiratory Drug Sales Price by Application (2019-2024) & (US$/Unit)
Table 150. Europe Respiratory Drug Sales Price by Application (2025-2030) & (US$/Unit)
Table 151. Europe Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 152. Europe Respiratory Drug Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 153. Europe Respiratory Drug Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 154. Europe Respiratory Drug Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 155. Europe Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 156. Europe Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 157. Europe Respiratory Drug Sales Price by Country (2019-2024) & (US$/Unit)
Table 158. Europe Respiratory Drug Sales Price by Country (2025-2030) & (US$/Unit)
Table 159. Germany Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 160. France Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 161. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 162. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 163. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 164. China Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 165. China Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 166. China Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 167. China Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 168. China Respiratory Drug Sales Price by Type (2019-2024) & (US$/Unit)
Table 169. China Respiratory Drug Sales Price by Type (2025-2030) & (US$/Unit)
Table 170. China Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 171. China Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 172. China Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 173. China Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 174. China Respiratory Drug Sales Price by Application (2019-2024) & (US$/Unit)
Table 175. China Respiratory Drug Sales Price by Application (2025-2030) & (US$/Unit)
Table 176. Asia Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 177. Asia Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 178. Asia Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 179. Asia Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 180. Asia Respiratory Drug Sales Price by Type (2019-2024) & (US$/Unit)
Table 181. Asia Respiratory Drug Sales Price by Type (2025-2030) & (US$/Unit)
Table 182. Asia Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 183. Asia Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 184. Asia Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 185. Asia Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 186. Asia Respiratory Drug Sales Price by Application (2019-2024) & (US$/Unit)
Table 187. Asia Respiratory Drug Sales Price by Application (2025-2030) & (US$/Unit)
Table 188. Asia Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 189. Asia Respiratory Drug Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 190. Asia Respiratory Drug Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 191. Asia Respiratory Drug Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 192. Asia Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 193. Asia Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 194. Asia Respiratory Drug Sales Price by Country (2019-2024) & (US$/Unit)
Table 195. Asia Respiratory Drug Sales Price by Country (2025-2030) & (US$/Unit)
Table 196. Japan Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 197. South Korea Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 198. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 199. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 200. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 201. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 202. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 203. Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 204. MEALA Respiratory Drug Revenue by Type (2019-2024) & (US$ Million)
Table 205. MEALA Respiratory Drug Revenue by Type (2025-2030) & (US$ Million)
Table 206. MEALA Respiratory Drug Sales by Type (2019-2024) & (M Units)
Table 207. MEALA Respiratory Drug Sales by Type (2025-2030) & (M Units)
Table 208. MEALA Respiratory Drug Sales Price by Type (2019-2024) & (US$/Unit)
Table 209. MEALA Respiratory Drug Sales Price by Type (2025-2030) & (US$/Unit)
Table 210. MEALA Respiratory Drug Revenue by Application (2019-2024) & (US$ Million)
Table 211. MEALA Respiratory Drug Revenue by Application (2025-2030) & (US$ Million)
Table 212. MEALA Respiratory Drug Sales by Application (2019-2024) & (M Units)
Table 213. MEALA Respiratory Drug Sales by Application (2025-2030) & (M Units)
Table 214. MEALA Respiratory Drug Sales Price by Application (2019-2024) & (US$/Unit)
Table 215. MEALA Respiratory Drug Sales Price by Application (2025-2030) & (US$/Unit)
Table 216. MEALA Respiratory Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 217. MEALA Respiratory Drug Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 218. MEALA Respiratory Drug Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 219. MEALA Respiratory Drug Sales by Country (2019 VS 2023 VS 2030) & (M Units)
Table 220. MEALA Respiratory Drug Sales by Country (2019-2024) & (M Units)
Table 221. MEALA Respiratory Drug Sales by Country (2025-2030) & (M Units)
Table 222. MEALA Respiratory Drug Sales Price by Country (2019-2024) & (US$/Unit)
Table 223. MEALA Respiratory Drug Sales Price by Country (2025-2030) & (US$/Unit)
Table 224. Mexico Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 225. Brazil Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 226. Israel Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 227. Argentina Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 228. Colombia Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 229. Turkey Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 230. Saudi Arabia Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 231. UAE Respiratory Drug Revenue (2019-2030) & (US$ Million)
Table 232. Key Raw Materials
Table 233. Raw Materials Key Suppliers
Table 234. Respiratory Drug Distributors List
Table 235. Respiratory Drug Customers List
Table 236. Research Programs/Design for This Report
Table 237. Authors List of This Report
Table 238. Secondary Sources
Table 239. Primary Sources
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Respiratory Drug Market Size Share 2019 VS 2023 VS 2030
Figure 4. Inhalable & Nasal Spray Picture
Figure 5. Oral Picture
Figure 6. Others Picture
Figure 7. Global Respiratory Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Respiratory Drug Market Size Share 2019 VS 2023 VS 2030
Figure 9. Hospital Picture
Figure 10. Drugs Store Picture
Figure 11. Global Respiratory Drug Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Respiratory Drug Revenue (2019-2030) & (US$ Million)
Figure 13. Global Respiratory Drug Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Respiratory Drug Revenue Market Share by Region: 2023 Versus 2030
Figure 15. Global Respiratory Drug Revenue Market Share by Region (2019-2030)
Figure 16. Global Respiratory Drug Sales (2019-2030) & (M Units)
Figure 17. Global Respiratory Drug Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Units)
Figure 18. Global Respiratory Drug Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Respiratory Drug Sales YoY (2019-2030) & (M Units)
Figure 20. Europe Respiratory Drug Sales YoY (2019-2030) & (M Units)
Figure 21. China Respiratory Drug Sales YoY (2019-2030) & (M Units)
Figure 22. Asia (Excluding China) Respiratory Drug Sales YoY (2019-2030) & (M Units)
Figure 23. Middle East, Africa and Latin America (Excluding China) Respiratory Drug Sales YoY (2019-2030) & (M Units)
Figure 24. Global Respiratory Drug Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 25. Global Respiratory Drug Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 27. Global Respiratory Drug Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Respiratory Drug Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 29. Global Respiratory Drug Revenue Market Share by Type (2019-2030)
Figure 30. Global Respiratory Drug Sales by Type (2019 VS 2023 VS 2030) & (M Units)
Figure 31. Global Respiratory Drug Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 32. Global Respiratory Drug Sales Market Share by Type (2019-2030)
Figure 33. Global Respiratory Drug Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 34. Global Respiratory Drug Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 35. Global Respiratory Drug Revenue Market Share by Application (2019-2030)
Figure 36. Global Respiratory Drug Sales by Application (2019 VS 2023 VS 2030) & (M Units)
Figure 37. Global Respiratory Drug Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 38. Global Respiratory Drug Sales Market Share by Application (2019-2030)
Figure 39. North America Respiratory Drug Revenue Share by Type (2019-2030)
Figure 40. North America Respiratory Drug Sales Share by Type (2019-2030)
Figure 41. North America Respiratory Drug Revenue Share by Application (2019-2030)
Figure 42. North America Respiratory Drug Sales Share by Application (2019-2030)
Figure 43. North America Respiratory Drug Revenue Share by Country (2019-2030)
Figure 44. North America Respiratory Drug Sales Share by Country (2019-2030)
Figure 45. Europe Respiratory Drug Revenue Share by Type (2019-2030)
Figure 46. Europe Respiratory Drug Sales Share by Type (2019-2030)
Figure 47. Europe Respiratory Drug Revenue Share by Application (2019-2030)
Figure 48. Europe Respiratory Drug Sales Share by Application (2019-2030)
Figure 49. Europe Respiratory Drug Revenue Share by Country (2019-2030)
Figure 50. Europe Respiratory Drug Sales Share by Country (2019-2030)
Figure 51. China Respiratory Drug Revenue Share by Type (2019-2030)
Figure 52. China Respiratory Drug Sales Share by Type (2019-2030)
Figure 53. China Respiratory Drug Revenue Share by Application (2019-2030)
Figure 54. China Respiratory Drug Sales Share by Application (2019-2030)
Figure 55. Asia Respiratory Drug Revenue Share by Type (2019-2030)
Figure 56. Asia Respiratory Drug Sales Share by Type (2019-2030)
Figure 57. Asia Respiratory Drug Revenue Share by Application (2019-2030)
Figure 58. Asia Respiratory Drug Sales Share by Application (2019-2030)
Figure 59. Asia Respiratory Drug Revenue Share by Country (2019-2030)
Figure 60. Asia Respiratory Drug Sales Share by Country (2019-2030)
Figure 61. MEALA Respiratory Drug Revenue Share by Type (2019-2030)
Figure 62. MEALA Respiratory Drug Sales Share by Type (2019-2030)
Figure 63. MEALA Respiratory Drug Revenue Share by Application (2019-2030)
Figure 64. MEALA Respiratory Drug Sales Share by Application (2019-2030)
Figure 65. MEALA Respiratory Drug Revenue Share by Country (2019-2030)
Figure 66. MEALA Respiratory Drug Sales Share by Country (2019-2030)
Figure 67. Respiratory Drug Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Respiratory Drug Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
